OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $1.24 billion. The enterprise value is $1.37 billion.
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 742.51 million shares outstanding. The number of shares has increased by 3.81% in one year.
| Current Share Class | 742.51M |
| Shares Outstanding | 742.51M |
| Shares Change (YoY) | +3.81% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 43.44% |
| Owned by Institutions (%) | 26.15% |
| Float | 319.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.84 |
| Forward PS | 4.47 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 5.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.46.
| Current Ratio | 4.97 |
| Quick Ratio | 2.95 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.85 |
Financial Efficiency
Return on equity (ROE) is -8.90% and return on invested capital (ROIC) is -14.35%.
| Return on Equity (ROE) | -8.90% |
| Return on Assets (ROA) | -5.85% |
| Return on Invested Capital (ROIC) | -14.35% |
| Return on Capital Employed (ROCE) | -10.57% |
| Weighted Average Cost of Capital (WACC) | 11.03% |
| Revenue Per Employee | $287,515 |
| Profits Per Employee | -$65,079 |
| Employee Count | 2,275 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 8.51 |
Taxes
| Income Tax | -5.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.56% in the last 52 weeks. The beta is 1.53, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +26.56% |
| 50-Day Moving Average | 1.60 |
| 200-Day Moving Average | 1.37 |
| Relative Strength Index (RSI) | 47.00 |
| Average Volume (20 Days) | 3,359,222 |
Short Selling Information
The latest short interest is 32.85 million, so 4.42% of the outstanding shares have been sold short.
| Short Interest | 32.85M |
| Short Previous Month | 34.01M |
| Short % of Shares Out | 4.42% |
| Short % of Float | 10.27% |
| Short Ratio (days to cover) | 6.54 |
Income Statement
In the last 12 months, OPKO Health had revenue of $654.10 million and -$148.06 million in losses. Loss per share was -$0.20.
| Revenue | 654.10M |
| Gross Profit | 128.41M |
| Operating Income | -181.51M |
| Pretax Income | -113.18M |
| Net Income | -148.06M |
| EBITDA | -91.80M |
| EBIT | -181.51M |
| Loss Per Share | -$0.20 |
Full Income Statement Balance Sheet
The company has $384.04 million in cash and $515.65 million in debt, with a net cash position of -$131.61 million or -$0.18 per share.
| Cash & Cash Equivalents | 384.04M |
| Total Debt | 515.65M |
| Net Cash | -131.61M |
| Net Cash Per Share | -$0.18 |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 1.50 |
| Working Capital | 643.92M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$125.05 million and capital expenditures -$10.29 million, giving a free cash flow of -$135.34 million.
| Operating Cash Flow | -125.05M |
| Capital Expenditures | -10.29M |
| Depreciation & Amortization | 89.71M |
| Net Borrowing | 123.14M |
| Free Cash Flow | -135.34M |
| FCF Per Share | -$0.18 |
Full Cash Flow Statement Margins
Gross margin is 19.63%, with operating and profit margins of -27.75% and -22.64%.
| Gross Margin | 19.63% |
| Operating Margin | -27.75% |
| Pretax Margin | -17.30% |
| Profit Margin | -22.64% |
| EBITDA Margin | -14.03% |
| EBIT Margin | -27.75% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.81% |
| Shareholder Yield | -3.81% |
| Earnings Yield | -11.72% |
| FCF Yield | -11.25% |
Analyst Forecast
The average price target for OPKO Health is $4.15, which is 148.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.15 |
| Price Target Difference | 148.50% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -22.23% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.55 |
| Piotroski F-Score | 3 |